| Line Item | 2022-12-30 | Y/Y |
|---|---|---|
| Revenue | $14.40B | +4.8% |
| Cost of Revenue | $12.31B | +5.0% |
| R&D Expense | $116.0M | +6.4% |
| SG&A Expense | $950.0M | +10.5% |
| Operating Income | $1.09B | -5.6% |
| Pre-tax Income | $886.0M | -8.4% |
| Income Tax | $193.0M | -7.2% |
| Net Income | $685.0M | -9.0% |
| EPS (Basic) | $5.00 |
| Line Item | 2022-12-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $516.0M | -29.0% |
| Accounts Receivable | $2.35B | +7.4% |
| Inventory | $287.0M | +4.7% |
| Current Assets | $3.64B | +0.7% |
| Total Assets | $13.07B | -1.4% |
| Current Liabilities | $3.95B | +22.2% |
| Long-term Debt | $3.93B | -14.5% |
| Line Item | 2022-12-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $986.0M | -4.4% |
| Investing Cash Flow | -$313.0M | +57.1% |
| Financing Cash Flow | -$865.0M | -665.5% |
| -6.4% |
| EPS (Diluted) | $4.96 | -5.9% |
| Total Liabilities |
| $8.72B |
| -2.2% |
| Stockholders' Equity | $4.30B | +0.2% |